Role of microRNA miR-34a in liver cancer stem cells

Authors

  • Lu-Lu Gong Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun 130041
  • Shu-Li Yang Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun 130041
  • Guo-Feng Zhang Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun 130041
  • Jia-Chengi Wu Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun 130041
  • Rui-Xin Lin Department of Hepato-Biliary-Pancreatic Surgery, The Second Hospital of Jilin University, Changchun 130041

DOI:

https://doi.org/10.3329/bjp.v11i2.24975

Keywords:

Liver cancer, microRNA, miR-34a, Stem cell

Abstract

The present study focuses on the role of microRNA miR-34a in liver cancer stem cells. Liver tissue samples were collected from the control and liver cancer patients. Immunohistochemistry experiment with CD90 antibodies suggests that the liver cancer stem cells were present in the liver cancer tissue samples. Interestingly, flow cytometry analysis followed by qRT-PCR confirmed that the CD90+ cells also called as liver cancer stem cells shows expression of miR-34a at the levels of 30-80%, when compared with that of normal liver tissue samples. The present study concludes that the liver cancer stem cells shows high expression of miR-34a, which is the important target unique to liver cancer stem cells in order to design liver cancer stem cells-specific therapies.

Downloads

Download data is not yet available.
Abstract
1555
Download
853 Read
725

Downloads

Additional Files

Published

2016-03-18

How to Cite

Gong, L.-L., S.-L. Yang, G.-F. Zhang, J.-C. Wu, and R.-X. Lin. “Role of MicroRNA MiR-34a in Liver Cancer Stem Cells”. Bangladesh Journal of Pharmacology, vol. 11, no. 2, Mar. 2016, pp. 333-6, doi:10.3329/bjp.v11i2.24975.

Issue

Vol. 11 No. 2 (2016)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).